Because previous conclusions on the PI3K pathway in glioma were primarily restricted to the scope of PI3K kinases, PTEN, and mTOR mutations, we sought to elaborate on other PI3K pathway genes. This evidence concerns the gene PIK3CA and central nervous system cancer.